Ä¿¹Â´ÏƼ

¾¾¾ÆÀ̹ÙÀÌ¿À´Â ¹ÏÀ½°ú ½Å·Ú¸¦ ¹ÙÅÁÀ¸·Î
±Í»çÀÇ ±¹³», ÇØ¿ÜÁøÃâÀÇ ÆÄÆ®³Ê°¡ µÇ°Ú½À´Ï´Ù.

Ä¿¹Â´ÏƼ

  • Ȩ
  • Ä¿¹Â´ÏƼ
  • ÀÚ·á½Ç

ÀÚ·á½Ç

¹øÈ£ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏÀÚ Á¶È¸¼ö
°øÁö Licence in, out , sales service °ü¸®ÀÚ 2024-07-09 63
°øÁö FDA ÄÁ¼³ÆÃ, ¹Ì±¹ ÁøÃâ ½ÃÀåÁ¶»ç, Áö¿ø µå¸³´Ï´Ù. °ü¸®ÀÚ 2023-03-27 118
°øÁö EU Regulatory MDD ¿¡¼­ MDR, IVDR Àüȯ¿¡ µû¸¥ Clinical trialÀ» Æ÷ÇÔÇÑ Áö¿ø¹× Áغñ.. °ü¸®ÀÚ 2023-03-27 91
13 Drug development raw materials °ü¸®ÀÚ 2024-10-25 15
12 Cell therapy capabilitiy from IIT , pre-clinical and IND stages (CAR-T, CAR-NK,.. °ü¸®ÀÚ 2024-09-27 34
11 Cell therapy ,Lentiviral Vector, mRNA , Plasmid Service °ü¸®ÀÚ 2024-09-27 32
10 ADC Manufacturing .IND Service(US FDA,EU EMA, Pmda,etc) °ü¸®ÀÚ 2024-07-02 96
9 Medical related area, Refer to reference (Notice) °ü¸®ÀÚ 2024-03-14 102
8 diagnostics test °ü¸®ÀÚ 2023-04-02 130
7 ÇØ¿ÜÀÓ»ó, µî·Ï °í·Á»çÇ×¹× ÁøÇà¹æÇâ (Clinical trial, registration capability For .. °ü¸®ÀÚ 2023-03-13 96